Publications

Istanbullu, H., Bayraktar, G., Karakaya, G., Akbaba, H., Perk, N. E., Cavus, I., Podlipnik, C., Yereli, K., Ozbilgin, A., Debelec Butuner, B., & Alptuzun, V. (2023). Design, synthesis, in vitro – In vivo biological evaluation of novel thiazolopyrimidine compounds as antileishmanial agent with PTR1 inhibition. European Journal of Medicinal Chemistry (Vol. 247, p. 115049). Elsevier BV. https://doi.org/10.1016/j.ejmech.2022.115049

Hasan Akbaba, Gülşah Erel-Akbaba, Yücel Başpınar, and Şerif Şentürk, Design of Liposome Formulations for CRISPR/Cas9 Enzyme Immobilization: Evaluation of 5-Alpha-Reductase Enzyme Knockout for Androgenic Disorders, ACS Omega DOI: 10.1021/acsomega.3c07138

Özder, M., Erçetin, Y., & Akbaba, H. (2023). Molecular and Cellular Basics of Intermittent Fasting: Traditional Review. In Journal of Literature Pharmacy Sciences (Vol. 12, Issue 2, pp. 123–134). Turkiye Klinikleri. https://doi.org/10.5336/pharmsci.2022-94991

Mora-Buch, R., Akbaba, H., Bromley, S.K. (2023). Interactions of Tissue-Resident T Cells. In: Baldari, C.T., Dustin, M.L. (eds) The Immune Synapse. Methods in Molecular Biology, vol 2654. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3135-5_28

Akbaba, H., Baspinar, Y. (2023). Aşı Çalışmaları ve Teknolojisi- Aşıların Nanoformülasyonu. Nobel Tıp Kitabevi, TR, ISBN: 9786053358503

Debeleç-Butuner, B., Akbaba, H. (2023). Aşı Çalışmaları ve Teknolojisi– Kanser Aşıları ve İmmünoterapi. Nobel Tıp Kitabevi, TR, ISBN: 9786053358503

Kotmakci, M. Akbaba, H. (2023). Aşı Çalışmaları ve Teknolojisi- Aşı Ruhsat Dosyası ve Yasal Otorite. Nobel Tıp Kitabevi, TR, ISBN: 9786053358503

Selen İsar, Hasan Akbaba, Yiğit Şahİn, Meric A. Altinöz, Ayşe Nalbantsoy, Gülşah Erel-Akbaba & Yücel Başpınar (2022) Design and evaluation of erucic acidphytosphingosine structured cationic nanoemulsions as a plasmid DNA delivery system against breast cancer cells, Pharmaceutical Development and Technology, 27:2, 145-154, DOI: 10.1080/10837450.2021.2025247

Gulsah Erel-Akbaba, Hasan Akbaba, Erdi Keselik, Selen Akyol Bahceci, Zeynep Senyigit, Tijen Kaya Temiz, Octaarginine functionalized nanoencapsulated system: In vitro and in vivo evaluation of bFGF loaded formulation for wound healing,
Journal of Drug Delivery Science and Technology, Volume 71,2022, 103343,https://doi.org/10.1016/j.jddst.2022.103343.

Ekinci, M., Akbaba, H., Santos-Oliveira, R., & Ilem-Ozdemir, D. (2022, March 14). Development and validation of UV/VIS spectroscopy method for determination of atezolizumab in pharmaceutical products. Experimental Biomedical Research, 5(2), 175-182. https://doi.org/https://doi.org/10.30714/j-ebr.2022275813

Isar, S. , Şahin, H. Y. , Akbaba, H. , Nalbantsoy, A. , Erel Akbaba, G. & Başpınar, Y. (2022). Long-term Stability of Cationic Phytosphingosine Nanoemulsions as Delivery Systems for plasmid DNA . Celal Bayar University Journal of Science , 18 (1) , 107-118 . DOI: 10.18466/cbayarfbe.948114

Akbaba, H. , Erel-akbaba, G. & Kantarcı, A. G. (2022). Fabrication and Evaluation of Cationic Charged Magnetic Nanoparticles for Enhanced Gene Delivery . Fabad Journal of Pharmaceutical Sciences , 47 (2) , 201-212 .

Ekinci, M., dos Santos, C. C., Alencar, L. M. R., Akbaba, H., Santos-Oliveira, R., & Ilem-Ozdemir, D. (2022). Atezolizumab-Conjugated Poly(lactic acid)/Poly(vinyl alcohol) Nanoparticles as Pharmaceutical Part Candidates for Radiopharmaceuticals. ACS Omega (Vol. 7, Issue 51, pp. 47956–47966). American Chemical Society (ACS).

Erel-Akbaba, G., Akbaba, H. Investigation of the potential therapeutic effect of cationic lipoplex mediated fibroblast growth factor-2 encoding plasmid DNA delivery on wound healing. DARU J Pharm Sci 29, 329–340 (2021). https://doi.org/10.1007/s40199-021-00410-y

Akbaba H, Erel-Akbaba G, Senturk S,  Recruitment of solid lipid nanoparticles for the delivery of CRISPR/Cas9: primary evaluation of anticancer gene editing, Nanomedicine, 10.2217/nnm-2020-0412

Erel-Akbaba G, İsar S, Akbaba H. Development and Evaluation of Solid Witepsol Nanoparticles for Gene Delivery. Turk J Pharm Sci. 2021;18(3):344-351. doi:10.4274/tjps.galenos.2020.68878

Erel-Akbaba G, Akbaba H. A comparative study of cationic liposomes for gene delivery. J.Res.Pharm. 2021; 25(4): 398-406. http://dx.doi.org/10.29228/jrp.30

Akbaba, H., Özder, M. Optimization and screening of solid lipid nanoparticle production for gene delivery by factorial design and response surface methodology. Experimental Biomedical Research, 2021; 4(1): 23-37

Başpınar Y. , Akbaba H.Biosynthesis of Curcumin and Molecular Targets and the Biological Mechanism of Curcumin The Chemistry and Bioactive Components of Turmeric., Sreeraj Gopi,Sabu Thomas,Ajaikumar B Kunnumakkara,Bharat B Aggarwal,Augustine Amalraj, Editör, Royal Society of Chemistry , London, ss.196-220, 2021

Bromley SK, Akbaba H, Mani V, Mora-buch R, Chasse AY, Sama A, Luster AD,. CD49a Regulates Cutaneous Resident Memory CD8 + T Cell Persistence and Response,  CellReports, 2020;32(9):108085.

Akbaba H, Erel-Akbaba G, Kotmakçı M, Başpınar Y. Enhanced Cellular Uptake and Gene Silencing Activity of Survivin-siRNA via Ultrasound-Mediated Nanobubbles in Lung Cancer Cells. Pharm Res. 2020;37(8).  

Istanbullu H., Bayraktar G., Akbaba H., Cavus İ., Coban G., Debelec-Butuner B., Kilimcioglu A.A., Ozbilgin A., Alptuzun V., Erciyas E., Design, synthesis and in vitro biological evaluation of novel thiazolopyrimidine derivatives as antileishmanial compounds.  Archiv der Pharmazie. 2020;DOI: 10.1002/ardp.201900325

Başpinar Y, Akbaba H, Bayraktar O. Encapsulation of paclitaxel in electrosprayed chitosan nanoparticles. J. Res. Pharm. 2019;23(5):886–96

Akbaba H., Resident Memory T Cells.  Cells of the Immune System, 1st ed. InTechOpen; Croatia; 2020, http://dx.doi.org/10.5772/intechopen.90334

Baspınar Y., Erel-Akbaba G., Kotmakçı M., Akbaba H., Development and characterization of nanobubbles containing paclitaxel and survivin inhibitor YM155 against lung cancer. Int J Pharm., 2019;566:149-156

Erel-Akbaba G, Carvalho LA, Tian T, Zinter M, Akbaba H, Obeid PJ, Chiocca EA., Weissleder R., Kantarcı A.G., Tannous B.,  Radiation-induced targeted nanoparticle-based gene delivery for brain tumor therapy. ACS Nano. American Chemical Society. 2019;13(4):4028–40.

Başpinar Y, Akbaba H, Bayraktar O. Encapsulation of paclitaxel in electrosprayed chitosan nanoparticles. J. Res. Pharm. 2019;23(5):886–96

Karagöz U., Kotmakçı M., Akbaba H., Çetintaş V.B., Kantarcı G., Preparation and characterization of non-viral gene delivery systems with pEGFP-C1 Plasmid DNA. Brazilian J. Pharm. Sci. 2018;54:1–11.

Akbaba H., Erel-Akbaba G., Kantarcı A.G., Development and evaluation of antisense shRNA-encoding plasmid loaded solid lipid nanoparticles against 5-α reductase activity. J. Drug Deliv. Sci. Technol. 2018;44:270–277.

Kotmakçı M., Akbaba H., Erel G., Ertan G., Kantarcı G., Improved Method for Solid Lipid Nanoparticle Preparation Based on Hot Microemulsions: Preparation, Characterization, Cytotoxicity, and Hemocompatibility Evaluation. AAPS PharmSciTech 2017;18:1355–1365

Akbaba H., Karagöz U., Selamet Y., Kantarcı A.G., Synthesis and characterization of cationic lipid coated magnetic nanoparticles using multiple emulsions as microreactors. J. Magn. Magn. Mater. 2017;426: 518–524.

Erel G., Kotmakçı M., Akbaba H., Sözer Karadağlı S., Kantarcı A.G., Nanoencapsulated chitosan nanoparticles in emulsion-based oral delivery system: In vitro and in vivo evaluation of insulin loaded formulation. J. Drug Deliv. Sci. Technol. 2016;36:161–167

Akbaba H., Demir Dora D., Kantarcı A.G., The effects of lyophilization and cryoprotectants on solid lipid nanoparticle-DNA systems. Rom. Biotechnol. Lett. 2017;22,:13186–13195

Akbaba H, Selamet Y, Kantarcı A. G., In situ production of cationic lipid coated magnetic nanoparticles in multiple emulsions for gene delivery. Marmara Pharm. J 2016; 20(2): 072-078. http://dx.doi.org/10.12991/mpj.20162069254